Nuclear Medicine: Page 99

GE awarded HealthTrust purchasing deal

By AuntMinnie.com staff writers

GE Healthcare will provide SPECT and PET radiopharmaceuticals to members of the HealthTrust group purchasing organization across the U.S.

April 5, 2017

Reduced FDG dose levels for PET/MRI show mixed results

By Wayne Forrest

Even though a lower dose of FDG did not significantly affect lesion detection for most adult cancer patients undergoing a whole-body PET/MRI scan, German researchers recommend that clinicians stay with recommended levels to avoid artifacts, according to a study published in the Journal of Nuclear Medicine.

April 5, 2017

PET identifies cell mutations in NSCLC patients

By AuntMinnie.com staff writers

With the help of FDG-PET and an advanced image analysis technique known as radiomics, researchers have identified genetic cell mutations that can cause non-small cell lung cancer (NSCLC), according to a study published in the April issue of the Journal of Nuclear Medicine.

April 3, 2017

Role of imaging modalities is changing for PE diagnosis

By Eric Barnes

The use of ventilation/perfusion SPECT scans to rule out pulmonary embolism (PE) is evolving. What used to be the definitive test for PE is shifting into a role that harmonizes with the use of pulmonary CT angiography, according to an article in the American Journal of Roentgenology.

March 30, 2017

Navidea posts year-end revenue increase

By AuntMinnie.com staff writers

Radiopharmaceutical developer Navidea Biopharmaceuticals has posted a revenue increase for its fiscal 2016.

March 29, 2017

University of Missouri to produce Mo-99

By AuntMinnie.com staff writers

The University of Missouri Research Reactor in Columbia, MO, has submitted a request to the U.S. Nuclear Regulatory Commission to produce medical isotopes, specifically molybdenum-99 (Mo-99).

March 28, 2017